{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:08:39Z","timestamp":1763809719637},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European Commission FP7 Grant","award":["281654 TAIN"],"award-info":[{"award-number":["281654 TAIN"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s40262-017-0575-8","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T08:43:19Z","timestamp":1501490599000},"page":"515-527","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults"],"prefix":"10.1007","volume":"57","author":[{"given":"Johanna","family":"Melin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zinnia P.","family":"Parra-Guillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelm","family":"Huisinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Kloft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"575_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:364\u201389.","journal-title":"J Clin Endocrinol Metab."},{"key":"575_CR2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/archdischild-2015-309538","volume":"102","author":"J Porter","year":"2017","unstructured":"Porter J, Blair J, Ross RJ. Is physiological glucocorticoid replacement important in children? Arch Dis Child. 2017;102:199\u2013205.","journal-title":"Arch Dis Child."},{"key":"575_CR3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/jps.2600710522","volume":"71","author":"RD Toothaker","year":"1982","unstructured":"Toothaker RD, Sundaresan GM, Hunt JP, Goehl TJ, Rotenberg KS, Prasad VK, et al. Oral hydrocortisone pharmacokinetics: a comparison of fluorescence and ultraviolet high-pressure liquid. J Pharm Sci. 1982;71:573\u20136.","journal-title":"J Pharm Sci."},{"key":"575_CR4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/j.1552-4604.1991.tb01906.x","volume":"31","author":"H Derendorf","year":"1991","unstructured":"Derendorf H, Mollmann H, Barth J, Mollmann C, Tunn S, Krieg M. Pharmacokinetics and oral bioavailability of hydrocortisone. J Clin Pharm. 1991;31:473\u20136.","journal-title":"J Clin Pharm."},{"key":"575_CR5","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4133\u201360.","journal-title":"J Clin Endocrinol Metab."},{"key":"575_CR6","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1210\/jc.2014-4060","volume":"100","author":"MJ Whitaker","year":"2015","unstructured":"Whitaker MJ, Spielmann S, Digweed D, Huatan H, Eckland D, Johnson TN, et al. Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency. J Clin Endocrinol Metab. 2015;100:1681\u20138.","journal-title":"J Clin Endocrinol Metab."},{"key":"575_CR7","doi-asserted-by":"crossref","unstructured":"Kauzor D, Spielmann S, Brosig H, Ross R, Blankenstein O, Kloft C. Medication safety study investigating hydrocortisone individually and extemporaneously compounded capsules for paediatric use in CAH [abstract no. P825]. 16th European Congress of Endocrinology, 2014. http:\/\/www.endocrine-abstracts.org\/ea\/0035\/ea0035P825.htm . Accessed 25 Jun 2017.","DOI":"10.1530\/endoabs.35.P825"},{"key":"575_CR8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/jcem.86.1.7275","volume":"86","author":"DP Merke","year":"2001","unstructured":"Merke DP, Cho D, Calis KA, Keil MF, Chrousos GP. Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86:441\u20135.","journal-title":"J Clin Endocrinol Metab."},{"key":"575_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF01062332","volume":"10","author":"RD Toothaker","year":"1982","unstructured":"Toothaker RD, Welling PG. Effect of dose size on the pharmacokinetics of intravenous hydrocortisone during endogenous hydrocortisone suppression. J Pharmacokinet Biopharm. 1982;10:147\u201356.","journal-title":"J Pharmacokinet Biopharm."},{"key":"575_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jcem.84.2.5461","volume":"84","author":"EGWM Lentjes","year":"1999","unstructured":"Lentjes EGWM. Romijn FHTPM. Temperature-dependent cortisol distribution among the blood compartments in man. J Clin Endocrinol Metab. 1999;84:682\u20137.","journal-title":"J Clin Endocrinol Metab."},{"key":"575_CR11","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jps.2600711029","volume":"71","author":"RD Toothaker","year":"1982","unstructured":"Toothaker RD, Craig WA, Welling PG. Effect of dose size on the pharmacokinetics of oral hydrocortisone suspension. J Pharm Sci. 1982;71:1182\u20135.","journal-title":"J Pharm Sci."},{"key":"575_CR12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.2004.02106.x","volume":"61","author":"PM Mah","year":"2004","unstructured":"Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, et al. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol. 2004;61:367\u201375.","journal-title":"Clin Endocrinol."},{"key":"575_CR13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/11531290-000000000-00000","volume":"49","author":"N Simon","year":"2010","unstructured":"Simon N, Castinetti F, Ouliac F, Lesavre N, Brue T, Oliver C. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets. Clin Pharmacokinet. 2010;49:455\u201363.","journal-title":"Clin Pharmacokinet."},{"key":"575_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2005.02412.x","volume":"64","author":"M Hoshiro","year":"2006","unstructured":"Hoshiro M, Ohno Y, Masaki H, Iwase H, Aoki N. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients. Clin Endocrinol. 2006;64:37\u201345.","journal-title":"Clin Endocrinol."},{"key":"575_CR15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1210\/jc.2015-3694","volume":"101","author":"M Debono","year":"2016","unstructured":"Debono M, Harrison RF, Whitaker MJ, Eckland D, Arlt W, Keevil BG, et al. Salivary cortisone reflects cortisol exposure under physiological conditions and after hydrocortisone. J Clin Endocrinol Metab. 2016;101:1469\u201377.","journal-title":"J Clin Endocrinol Metab."},{"key":"575_CR16","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA."},{"key":"575_CR17","unstructured":"Association of the British Pharmaceutical Industry. Guidelines for phase 1 clinical trials (2012 edition). http:\/\/www.abpi.org.uk\/our-work\/library\/guidelines\/Pages\/phase-1-trials-2012.aspx . Accessed 18 Nov 2016."},{"key":"575_CR18","unstructured":"International Council for Harmonisation of Technical Requirements for Human Use. Guideline for good clinical practice E6(R1). http:\/\/www.ich.org\/products\/guidelines\/efficacy\/efficacy-single\/article\/good-clinical-practice.html . Accessed 18 Nov 2016."},{"key":"575_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0009-8981(02)00417-5","volume":"328","author":"JG Lewis","year":"2003","unstructured":"Lewis JG, Lewis MG, Elder PA. An enzyme-linked immunosorbent assay for corticosteroid-binding globulin using monoclonal and polyclonal antibodies: decline in CBG following synthetic ACTH. Clin Chim Acta. 2003;328:121\u20138.","journal-title":"Clin Chim Acta."},{"key":"575_CR20","unstructured":"Beal S, Sheiner LB, Boeckmann A, Bauer RJ. NONMEM user\u2019s guides (1989\u20132009). Ellicott City: Icon Development Solutions; 2009."},{"key":"575_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom L, Pihlgren P, Jonsson EN, Jonsson N. PsN-Toolkit\u2013a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005;79:241\u201357.","journal-title":"Comput Methods Programs Biomed."},{"key":"575_CR22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10928-008-9088-2","volume":"35","author":"C Dansirikul","year":"2008","unstructured":"Dansirikul C, Silber HE, Karlsson MO. Approaches to handling pharmacodynamic baseline responses. J Pharmacokinet Pharmacodyn. 2008;35:269\u201383.","journal-title":"J Pharmacokinet Pharmacodyn."},{"key":"575_CR23","unstructured":"Keizer R, Pastoor D, Savic R. New open source R libraries for simulation and visualization: \u201cPKPDsim\u201d and \u201cvpc\u201d 2015. http:\/\/www.page-meeting.eu\/pdf_assets\/1215-Page_Keizer_2015_pkpdsim_vpc.pdf . Accessed 5 Oct 2016."},{"key":"575_CR24","unstructured":"R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2016. ISBN 3-900051-07-0. http:\/\/www.R-project.org . Accessed 15 June 2016."},{"key":"575_CR25","first-page":"536","volume":"82","author":"U Knutsson","year":"1997","unstructured":"Knutsson U, Dahlgren J, Marcus C, Rosberg S, Br\u00f6nneg\u00e5rd M, Stierna P, et al. Circadian cortisol rhythms in healthy boys and girls: relationship with age, growth, body composition, and pubertal development. J Clin Endocrinol Metab. 1997;82:536\u201340.","journal-title":"J Clin Endocrinol Metab."},{"key":"575_CR26","unstructured":"Rohatgi A. WebPlotDigitizer. http:\/\/arohatgi.info\/WebPlotDigitizer . Accessed 5 Oct 2016."},{"key":"575_CR27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bcp.12131","volume":"76","author":"DH Wright","year":"2013","unstructured":"Wright DH, Stone JA, Crumley TM, Wenning L, Zheng W, Yan K, et al. Pharmacokinetic-pharmacodynamic studies of the 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor MK-0916 in healthy subjects. Br J Clin Pharmacol. 2013;76:917\u201331.","journal-title":"Br J Clin Pharmacol."},{"key":"575_CR28","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1152\/ajpendo.2001.281.5.E946","volume":"281","author":"N Picard-Hagen","year":"2001","unstructured":"Picard-Hagen N, Gayrard V, Alvinerie M, Smeyers H, Ricou R, Bousquet-Melou A, et al. A nonlabeled method to evaluate cortisol production rate by modeling plasma CBG-free cortisol disposition. Am J Physiol Endocrinol Metab. 2001;281:E946\u201356.","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"575_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1677\/joe.0.1690065","volume":"169","author":"E Charmandari","year":"2001","unstructured":"Charmandari E, Johnston A, Brook CG, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol. 2001;169:65\u201370.","journal-title":"J Endocrinol"},{"key":"575_CR30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1517\/17425255.4.6.749","volume":"4","author":"H Lennern\u00e4s","year":"2008","unstructured":"Lennern\u00e4s H, Skrtic S, Johannsson G. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors. Expert Opin Drug Metab Toxicol. 2008;4:749\u201358.","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"575_CR31","doi-asserted-by":"crossref","unstructured":"Westphal U. Steroid-protein interactions. In: Gross F, Labhart A, Mann T, Samuels L (eds.) 1st edn. New York: Springer; 1971.","DOI":"10.1007\/978-3-642-46262-7"},{"key":"575_CR32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0003-9861(67)90390-6","volume":"118","author":"U Westphal","year":"1967","unstructured":"Westphal U. Steroid-protein interactions XIII. Concentrations and binding affinities of corticosteroid-binding globulins in sera of man, monkey, rat, rabbit and guinea pig. Arch Biochem Biophys. 1967;118:556\u201367.","journal-title":"Arch Biochem Biophys."},{"key":"575_CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0022-4731(87)90071-9","volume":"26","author":"J-L Coolens","year":"1987","unstructured":"Coolens J-L, Baelen HVAN, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem. 1987;26:197\u2013202.","journal-title":"J Steroid Biochem."},{"key":"575_CR34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2006-925338","volume":"38","author":"JG Lewis","year":"2006","unstructured":"Lewis JG, M\u00f6pert B, Shand BI, Doogue MP, Soule SG, Frampton CM, et al. Plasma variation of corticosteroid-binding globulin and sex hormone-binding globulin. Horm Metab Res. 2006;38:241\u20135.","journal-title":"Horm Metab Res."},{"key":"575_CR35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/cen.12982","volume":"84","author":"TT Chung","year":"2016","unstructured":"Chung TT, Gunganah K, Monson JP, Drake WM. Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin concentrations. Clin Endocrinol. 2016;84:496\u2013500.","journal-title":"Clin Endocrinol."},{"key":"575_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1067\/mcp.2002.121829","volume":"71","author":"LZ Benet","year":"2002","unstructured":"Benet LZ, Hoener B. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther. 2002;71:115\u201321.","journal-title":"Clin Pharmacol Ther."},{"key":"575_CR37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1203\/00006450-197501000-00008","volume":"9","author":"AJ Hadjian","year":"1975","unstructured":"Hadjian AJ, Chedin M, Cochet C, Chambaz EM. Cortisol binding to proteins in plasma in the human neonate and infant. Pediatr Res. 1975;9:40\u20135.","journal-title":"Pediatr Res."},{"key":"575_CR38","doi-asserted-by":"crossref","first-page":"E821","DOI":"10.1210\/jc.2013-3254","volume":"99","author":"SL Rogers","year":"2014","unstructured":"Rogers SL, Hughes BA, Jones CA, Freedman L, Smart K, Taylor N, et al. Diminished 11\u03b2-hydroxysteroid dehydrogenase type 2 activity is associated with decreased weight and weight gain across the first year of life. J Clin Endocrinol Metab. 2014;99:E821\u201331.","journal-title":"J Clin Endocrinol Metab."},{"key":"575_CR39","unstructured":"World Health Organisation. WHO child growth standards. 2006. http:\/\/www.who.int\/childgrowth\/standards\/Technical_report.pdf . Accessed 19 Apr 2017."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-017-0575-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-017-0575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-017-0575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T16:58:05Z","timestamp":1569949085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-017-0575-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1007\/s40262-017-0575-8","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]}}}